SHWZ - Medicine Man Technologies reports Q3 results guidance in line with consensus
- Medicine Man Technologies press release ( OTCQX:SHWZ ): Q3 Adjusted EBITDA of $15.9 Million.
- Revenue of $43.2M (+35.8% Y/Y).
- FY 2022 revenue is projected to be $155 million to $165 million, vs. consensus is $165.29M.
- FY 2022 adjusted EBITDA is projected to be from $51 million to $56 million.
For further details see:
Medicine Man Technologies reports Q3 results, guidance in line with consensus